Literature DB >> 15507959

Cerclage for prevention of preterm birth in women with a short cervix found on transvaginal ultrasound examination: a randomized trial.

Vincenzo Berghella1, Anthony O Odibo, Jorge E Tolosa.   

Abstract

OBJECTIVE: The purpose of this study was to determine the efficacy of cerclage and bed rest versus bed rest-only for the prevention of preterm birth in women with a short cervix found on transvaginal ultrasound examination. STUDY
DESIGN: Women with > or =1 of high-risk factors for preterm birth (> or =1 preterm birth at < 35 weeks of gestation, > or =2 curettages, diethylstilbestrol exposure, cone biopsy, Mullerian anomaly, or twin gestation) were screened with transvaginal ultrasonography of the cervix every 2 weeks from 14 weeks of gestation to 23 weeks 6 days of gestation. Enrollment was offered to both asymptomatic women who were at high risk and who were identified to have short cervix (< 25 mm) or significant funneling (>25%) and nonscreened women who were at low risk and who were identified incidentally. The women who gave written consent were assigned randomly to receive either McDonald cerclage or bed rest-only. Both groups received similar counseling and treatment. Primary outcome was preterm birth at < 35 weeks of gestation.
RESULTS: Sixty-one women were assigned randomly. Forty-seven pregnancies (77%) were high-risk singleton gestations. Thirty-one women (51%) were allocated to cerclage, and 30 women (49%) were allocated to bed rest. There were no differences between the groups in demographic characteristics, risk factors, and cervical variables. Preterm birth at < 35 weeks of gestation occurred in 14 women (45%) in the cerclage group and in 14 women (47%) in the bed rest group (relative risk, 0.94; 95% CI, 0.34-2.58). There was no difference in any obstetric or neonatal outcomes. A subanalysis of singleton pregnancies with previous preterm birth at < 35 weeks of gestation and a short cervix of < 25 mm (n = 31 women) also revealed no significant difference in recurrent preterm birth at < 35 weeks of gestation (40% vs 56%; relative risk, 0.52; 95% CI, 0.12-2.17).
CONCLUSION: Cerclage did not prevent preterm birth in women with a short cervix. These results should be confirmed by larger trials.

Entities:  

Mesh:

Year:  2004        PMID: 15507959     DOI: 10.1016/j.ajog.2004.06.054

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  35 in total

1.  Patients with an asymptomatic short cervix (<or=15 mm) have a high rate of subclinical intraamniotic inflammation: implications for patient counseling.

Authors:  Edi Vaisbuch; Sonia S Hassan; Shali Mazaki-Tovi; Chia-Ling Nhan-Chang; Juan Pedro Kusanovic; Tinnakorn Chaiworapongsa; Zhong Dong; Lami Yeo; Pooja Mittal; Bo Hyun Yoon; Roberto Romero
Journal:  Am J Obstet Gynecol       Date:  2010-05       Impact factor: 8.661

Review 2.  Cervical stitch (cerclage) for preventing pregnancy loss in women.

Authors:  A J Drakeley; D Roberts; Z Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2003

3.  Can the optimal cervical length for placing ultrasound-indicated cerclage be identified?

Authors:  J M Szychowski; J Owen; G Hankins; J D Iams; J S Sheffield; A Perez-Delboy; V Berghella; D A Wing; E R Guzman
Journal:  Ultrasound Obstet Gynecol       Date:  2016-05-29       Impact factor: 7.299

Review 4.  The role of cervical cerclage in obstetric practice: can the patient who could benefit from this procedure be identified?

Authors:  Roberto Romero; Jimmy Espinoza; Offer Erez; Sonia Hassan
Journal:  Am J Obstet Gynecol       Date:  2006-01       Impact factor: 8.661

Review 5.  Recurrent preterm birth.

Authors:  Shali Mazaki-Tovi; Roberto Romero; Juan Pedro Kusanovic; Offer Erez; Beth L Pineles; Francesca Gotsch; Pooja Mittal; Nandor Gabor Than; Jimmy Espinoza; Sonia S Hassan
Journal:  Semin Perinatol       Date:  2007-06       Impact factor: 3.300

6.  Prevention and Therapy of Preterm Birth. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Registry Number 015/025, February 2019) - Part 2 with Recommendations on the Tertiary Prevention of Preterm Birth and the Management of Preterm Premature Rupture of Membranes.

Authors:  Richard Berger; Harald Abele; Franz Bahlmann; Ivonne Bedei; Klaus Doubek; Ursula Felderhoff-Müser; Herbert Fluhr; Yves Garnier; Susanne Grylka-Baeschlin; Hanns Helmer; Egbert Herting; Markus Hoopmann; Irene Hösli; Udo Hoyme; Alexandra Jendreizeck; Harald Krentel; Ruben Kuon; Wolf Lütje; Silke Mader; Holger Maul; Werner Mendling; Barbara Mitschdörfer; Tatjana Nicin; Monika Nothacker; Dirk Olbertz; Werner Rath; Claudia Roll; Dietmar Schlembach; Ekkehard Schleußner; Florian Schütz; Vanadin Seifert-Klauss; Susanne Steppat; Daniel Surbek
Journal:  Geburtshilfe Frauenheilkd       Date:  2019-08-12       Impact factor: 2.915

7.  17-alpha-hydroxyprogesterone caproate for the prevention of preterm birth in women with prior preterm birth and a short cervical length.

Authors:  Vincenzo Berghella; Dana Figueroa; Jeff M Szychowski; John Owen; Gary D V Hankins; Jay D Iams; Jeanne S Sheffield; Annette Perez-Delboy; Deborah A Wing; Edwin R Guzman
Journal:  Am J Obstet Gynecol       Date:  2010-04       Impact factor: 8.661

8.  Timing of mid-trimester cervical length shortening in high-risk women.

Authors:  J M Szychowski; J Owen; G Hankins; J Iams; J Sheffield; A Perez-Delboy; V Berghella; D A Wing; E R Guzman
Journal:  Ultrasound Obstet Gynecol       Date:  2009-01       Impact factor: 7.299

9.  Evaluation of outcomes associated with placement of elective, urgent, and emergency cerclage.

Authors:  M J Khan; G Ali; G Al Tajir; H Sulieman
Journal:  J Obstet Gynaecol India       Date:  2012-08-21

Review 10.  Vaginal progesterone vs. cervical cerclage for the prevention of preterm birth in women with a sonographic short cervix, previous preterm birth, and singleton gestation: a systematic review and indirect comparison metaanalysis.

Authors:  Agustin Conde-Agudelo; Roberto Romero; Kypros Nicolaides; Tinnakorn Chaiworapongsa; John M O'Brien; Elcin Cetingoz; Eduardo da Fonseca; George Creasy; Priya Soma-Pillay; Shalini Fusey; Cetin Cam; Zarko Alfirevic; Sonia S Hassan
Journal:  Am J Obstet Gynecol       Date:  2012-11-15       Impact factor: 8.661

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.